Erection-aiding condom

Abstract

The invention relates to a condom (10) configured to wrap around the penis (40). It is characterized by said condom (10) comprising at least one receptacle (20) at an end portion (12) surrounding the head (41) of the penis (40) in which at least one fluid active ingredient (30) is stored, and said receptacle (20) comprising at least one delivery channel (22) extending from the wall of the end portion (12) towards the urethra (42) in order to direct the active ingredient (30) therein to the urethra (42).

Description

[0001] ERECTION-AIDING CONDOM

[0002] TECHNICAL FIELD

[0003] The invention relates to a condom configured to wrap around the penis.

[0004] PRIOR ART

[0005] There are a plurality of medications produced for men to help with erection. In addition to oral medications, there are also medications that are injected directly into the cavernous tissue of the penis. These medications can be used both in the treatment of erectile dysfunction and as sexual performance enhancers. The person can inject the active ingredient absorbed from the cavernous tissue into the penis with the help of an injector before sexual intercourse or use it by emptying it into the urethra with the help of a cannula. The active ingredient is absorbed from the cavernous tissue through both applications (injection through the skin or trans-urethral route) and shows the effect of vasodilation (enlargement of the vessels) in the cavernous tissue. In this way, the medications ensure that the penis is erected with blood.

[0006] The most common method of protection during sexual intercourse is the use of condoms. With the developing materials and medical technology, condoms can now be configured to meet different needs other than protection. Most of the men state that even if they do not have an erection problem, they may have erectile dysfunction or cannot maintain erection when they use a condom. This reduces the likelihood of using condoms and increases the risk of both sexually transmitted diseases and contraception. A person who is likely to have erectile dysfunction and who will have sexual intercourse using a condom must first take medication or inject an erectile active ingredient into the penis and then put the condom on the penis. Accordingly, it is necessary to supply the erectile agent and the condom separately. However, the application of the active ingredient before sexual intercourse separately is extra troublesome and time-consuming and can disrupt the spirit of sexuality.

[0007] The Application No. CN104161617A known in the literature is related to a condom. The object of the invention is to introduce a condom that provides a solution to problems such as erection loss and premature ejaculation. In order to achieve this, there is a receptacle at the end of the condom into which the medication is inserted. However, this receptacle is not suitable for directing the active ingredient into the urethra, and here the drug will be plastered on the penis. Therefore, for a person who needs the use of the active ingredient through the urethra, the condom described in the invention will be dysfunctional.

[0008] As a result, all the above-mentioned problems have made it imperative to make an innovation in the relevant technical field.

[0009] SUMMARY OF THE INVENTION

[0010] The present invention relates to a condom for eliminating the above-mentioned disadvantages and bringing new advantages to the relevant technical field.

[0011] An object of the invention is to introduce a condom that facilitates the uptake of the erectile agent through the urethra.

[0012] To achieve all the objects mentioned above and that will emerge from the following detailed description, the present invention is a condom configured to wrap around the penis. Accordingly, the novelty is that said condom comprises at least one receptacle at an end portion surrounding the head of the penis in which at least one fluid active ingredient is stored, said receptacle comprises at least one delivery channel extending from the wall of the end portion towards the urethra in order to direct the active ingredient therein to the urethra. Thus, a condom is introduced in which the active ingredient can be directed directly to the cavernous tissue.

[0013] A possible embodiment of the invention is characterized in that the receptacle comprises at least one active ingredient chamber containing the active ingredient, and the said active ingredient chamber is located at the end portion on the outside of the condom not facing the penis. Thus, the user can grasp the active ingredient chamber with his fingers and apply pressure to direct the active ingredient to the urethra. Another possible embodiment of the invention is characterized in that said active ingredient chamber is manufactured from flexible material to direct the active ingredient therein towards the delivery channel when pressure is applied.

[0014] Another possible embodiment of the invention is characterized in that the delivery channel has an annular cross-section. Thus, it is ensured that the delivery channel is suitable for the form of the urethra and can be easily inserted into the urethra.

[0015] Another possible embodiment of the invention is characterized in that the delivery channel is configured such that it narrows as it moves away from the end portion on a first axis in the direction of extension of the penis.

[0016] Another possible embodiment of the invention is characterized in that the delivery channel has a cylindrical form.

[0017] Another possible embodiment of the invention is characterized in that the active ingredient helps the penis to achieve an erection. Thus, it is ensured that the penis is erected and the hardness of the erect penis is maintained.

[0018] Another possible embodiment of the invention is characterized in that the outflow mouth through which the active ingredient passes into the urethra comprises a cover configured to allow passage of the active ingredient into the urethra by being deformed as a result of pressure applied by the active ingredient on the outflow mouth.

[0019] BRIEF DESCRIPTION OF DRAWINGS

[0020] Fig. 1 shows a representative front view of the condom of the invention.

[0021] Fig. 2 shows a representative front view of the usage of the condom of the invention.

[0022] DETAILED DESCRIPTION OF THE INVENTION

[0023] In this detailed description, the subject of the invention is explained by way of example only for a better understanding of the subject, which shall not create any limiting effect. Fig. 1 shows a representative front view of the condom (10) of the invention. Accordingly, said condom (10) is suitable for use in protective purposes by being worn over a penis (40). The condom (10) has a main surface (11) that at least partially surrounds the penis (40). Said main surface (11) extends in the same direction as the penis (40), on a first axis (I). Following the main surface (11), there is an end portion (12) surrounding the head (41) of the penis (40).

[0024] The condom (10) according to the invention comprises at least one receptacle (20) in said end portion (12). Said receptacle (20) has a cavity in which at least one active ingredient (30) can be stored. Said active ingredient (30) is in fluid state. The active ingredient (30) achieves erection for the penis (40). However, it is also possible to place different medication and different substances in the receptacle (20) in possible embodiments.

[0025] The condom (10) comprises at least one active ingredient chamber (21). Said active ingredient chamber (21) is the volume in which the active ingredient (30) is stored. There is at least one delivery channel (22) in the portion of the active ingredient chamber (21 ) facing the penis (40). Said delivery channel (22) is configured to extend from the end portion (10) of the condom (12) to the urethra (42) of the penis (40). Accordingly, the delivery channel (22) ensures that the active ingredient (30) in the receptacle (20) is transferred to the urethra (42).

[0026] The active ingredient chamber (21) is located on the outward-facing portion of the condom (10), opposite the end portion (12) and the head (41) of the penis (40). The delivery channel (22) is located in the portion of the condom (10) facing the head (41) of the penis (40). The delivery channel (22) comprises at least one outflow mouth (23). Said outflow mouth (23) is the opening allowing the active ingredient (30) in the chamber (20) to flow into the urethra (42). At least one cover (231) is connected to the outflow mouth (23). Said cover (231) is configured such that when pressure is applied on the receptacle (20) at a predetermined level, in other words, when the fluid pressure on the cover (231) reaches a predetermined level, it allows the fluid to pass through the outflow mouth (23). Accordingly, when the pressure exerted by the active ingredient (30) on the walls of the receptacle (20) is below the predetermined level, the cover (231 ) keeps the outflow mouth (23) closed. Thus, the active ingredient (30) in the receptacle (20) is taken out through the outflow mouth (23) only when desired. In the preferred embodiment, the cover (231) is configured to deform when said limit pressure is reached, thus allowing the passage of fluid through the outflow mouth (23). For this, the cover (231) is less durable than the rest of the receptacle (20).

[0027] The active ingredient chamber (21) is manufactured from stretchable material. In this way, when pressure is applied on the active ingredient chamber (21), the active ingredient (30) moves towards the delivery channel (22). In a possible embodiment, the active ingredient chamber (21) is manufactured from the same material as the main surface (11 ) of the condom (10).

[0028] The delivery channel (22) is manufactured from stretchable material to provide a comfortable use for the condom (10). The delivery channel (22) has an annular crosssection. However, in a possible embodiment, the delivery channel (22) is formed in a cylindrical structure in order to be placed in the urethra (42). In another possible embodiment, the delivery channel (22) is configured in a conical form for easier placement in the urethra (42). Accordingly, the delivery channel (22) is configured such that it narrows as it moves away from the end portion (12) on the first axis (I).

[0029] Fig. 2 shows a representative view of the usage of the condom (10) of the invention. Accordingly, with the placement of the condom (10) by the user, the delivery channel (22) is aligned with the urethra (42). With the form of the delivery channel (22), the user can easily place the delivery channel (22) in the urethra (42). Subsequently, when the user applies pressure to the active ingredient chamber (21) portion of the receptacle (20), the active ingredient (30) is directed to the delivery channel (22) with the pressure generated in the receptacle (20). Here, the cover (231 ) opens due to pressure. By opening the cover (231), the active ingredient (30) flows through the outflow mouth (23) into the urethra (42).

[0030] The active ingredient (30) has the property of causing vasodilation in the penis (40) and cavernous tissue (43). However, in possible embodiments, it is possible to place any medication, substance that needs to be taken through the urethra (42) into the receptacle (20). Due to the active ingredient of the invention (30) causing vasodilation in the cavernous tissue, erection of the penis (40) or maintaining the hardness of the erected penis (40) is achieved. Thus, with the condom (10) of the invention, the person can easily uptake the erectile active ingredient (30) that should be taken from the urethra (42) with the condom (10), and there is no need to take the erectile substance separately before putting on the condom (10)

[0031] The scope of protection of the invention is specified in the appended claims and cannot be limited to what is described for illustrative purposes in this detailed description. It is clear that a person skilled in the art can produce similar embodiments in the light of what is explained above, without deviating from the main theme of the invention.

[0032] REFERENCE NUMERALS GIVEN IN DRAWING

[0033] 10 Condom

[0034] 11 Main Surface

[0035] 12 End Portion

[0036] 20 Receptacle

[0037] 21 Active Ingredient Chamber

[0038] 22 Delivery Channel

[0039] 23 Outflow Mouth

[0040] 231 Cover

[0041] 30 Active Ingredient

[0042] 40 Penis

[0043] 41 Head

[0044] 42 Urethra

[0045] 43 Cavernous Tissue

[0046] (I) First Axis

Claims

CLAIMS1 . A condom (10) configured to wrap around the penis (40), characterized in that said condom (10) comprises at least one receptacle (20) at an end portion (12) surrounding the head (41 ) of the penis (40) in which at least one fluid active ingredient (30) is stored, said receptacle (20) comprises at least one delivery channel (22) extending from the wall of the end portion (12) towards the urethra (42) in order to direct the active ingredient (30) therein to the urethra (42).

2. A condom (10) according to claim 1 , characterized in that the receptacle (20) comprises at least one active ingredient chamber (21) containing the active ingredient (30), and the said active ingredient chamber (21) is located at the end portion (12) on the outside of the condom (10) not facing the penis (40).

3. A condom (10) according to claim 2, characterized in that said active ingredient chamber (21) is manufactured from flexible material to direct the active ingredient (30) therein towards the delivery channel (22) when pressure is applied.

4. A condom (10) according to claim 1 , characterized in that the delivery channel (22) has an annular cross-section.

5. A condom (10) according to claim 1 , characterized in that the delivery channel (22) is configured such that it narrows as it moves away from the end portion (12) on a first axis (I) in the direction of extension of the penis (40).

6. A condom (10) according to claim 1 , characterized in that the delivery channel(22) has a cylindrical form.

7. A condom (10) according to claim 1 , characterized in that the active ingredient (30) helps the penis (40) to achieve an erection.

8. A condom (10) according to claim 1 , characterized in that the outflow mouth(23) through which the active ingredient (30) passes into the urethra (42) comprises a cover (231) configured to allow passage of the active ingredient(30) into the urethra (42) by being deformed as a result of pressure applied by the active ingredient (30) on the outflow mouth (23).

Images